APPLICATION
ANDA208478
TYPE
ANDA
ORIGINAL APPROVAL
2020-06-23
LATEST ACTION
2025-02-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 10MG BASE · TABLET · ORAL
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 20MG BASE · TABLET · ORAL
Approval history
2025-02-07Labeling · Supplement 5 · standardAP
2024-02-05Labeling · Supplement 4 · standardAP
2022-10-25Labeling · Supplement 2 · standardAP
2020-06-23UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.